Canbi Pharma Tech Limited
1223403-58-4 Larotrectinib
1223403-58-4 Larotrectinib

1223403-58-4 Larotrectinib

CAS:1223403-58-4
MF:C21H22F2N6O2
MW:428.44
EINECS:
MDL No.:MFCD28902192

Send Inquiry
Description

Properties

Appearance Yellow solid
Density 1.55±0.1 g/cm3
storage temp. RT
solubility Soluble in DMSO (up to 5 mg/ml).
pka8.41±0.40
 

Application:

Larotrectinib is a highly selective TRK inhibitor that specifically targets tumors with NTRK gene fusion and exhibits significant inhibitory effects.

 

Synonyms:

Larotrectinib

1223403-58-4

(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide

LOXO 101

Vitrakvi

(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide

1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-

Larotrectinib (LOXO-101 free base)

1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-

larotrectinibum

(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide

Larotrectinib (Standard)

ARRY-470; larotrectinib

C21H22F2N6O2

(3S)-N-(5-((2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN- 1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE- 1-CARBOXAMIDE

(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide

(3S)-N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide

 

Hot Tags: 1223403-58-4 larotrectinib, China 1223403-58-4 larotrectinib manufacturers, suppliers, 3-Cyanophenylhydrazine, Cyclen, Mpeg-mal, Selexipag intermediate, 5-Bromo-3-nitropyridine-2-carbonitrile, Benzyl chloride

Inquiry
goTop

(0/10)

clearall